Anti-Microbial Savior BioteQ Co., Ltd.(TW:6864)
NT$36.70-1.10 (-2.91%)
TW:6864
Anti-Microbial Savior BioteQ Co., Ltd. Revenue
NT$36.70
At close:-1.10 (-2.91%)
Anti-Microbial Savior BioteQ Co., Ltd. (6864) Revenue
Anti-Microbial Savior BioteQ Co., Ltd. Revenue
Anti-Microbial Savior BioteQ Co., Ltd. had a revenue of 842.00K in the quarter ending Jun 30, 2026, with 102.40%. This bring the company's revenue in the last twelve months to 1.26M, Increased 78.19%. In the fiscal year ending Dec 31, 2025, Anti-Microbial Savior BioteQ Co., Ltd. had annual revenue of 706.00K with 15.36% growth.
- Revenue (ttm)
- 1.26M
- Revenue Growth
- 125.85%
- P/S Ratio
- 2027.85
- Revenue/Employee
- TWD 47,067
- Employees
- 15
- Market Cap
- TWD 1.43B
Revenue Chart
Anti-Microbial Savior BioteQ Co., Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 706.00K | 94.00K | 15.36% |
| Dec 31, 2024 | 612.00K | -116.00K | -15.93% |
| Dec 31, 2023 | 728.00K | -1.97M | -73.01% |
| Dec 31, 2022 | 2.70M | 2.61M | 2964.77% |
| Dec 31, 2021 | 88.00K | 15.00K | 20.55% |
| Dec 31, 2020 | 73.00K | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.